Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Abstracts from the 4th ImmunoTherapy of Cancer Conference

    J. Ženka, V. Caisová, O. Uher, P. Nedbalová in Journal for ImmunoTherapy of Cancer (2017)

  2. No Access

    Article

    Experimental simulation of dissimilar weld metal of high manganese steels by arc melting technique

    This paper presents an arc melting technique that allows simulating dissimilar weld metal of high manganese steels with ferritic and martensitic steel grades. The objective of this initial study was to conceiv...

    B . Wittig, M. Zinke, S. Jüttner, D. Keil in Welding in the World (2017)

  3. Article

    Open Access

    Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent

    Deoxyribonucleic acid (DNA) vaccines are used for experimental immunotherapy of equine melanoma. The injection of complexed linear DNA encoding interleukin (IL)-12/IL-18 induced partial tumour remission in a c...

    Christiane L. Schnabel, P. Steinig, M. Koy, H.-J. Schuberth in BMC Veterinary Research (2015)

  4. No Access

    Article

    Chronisch entzündliche Darmerkrankungen

    Pathogenese und Therapie der chronisch entzündlichen Darmerkrankungen sind gekennzeichnet durch eine auffällige Diskrepanz. Einerseits besteht weitgehend Übereinkunft, dass die Pathogenese wesentlich auf einer...

    K. Herrlinger, B. Wittig, Prof. Dr. E.F. Stange in Der Internist (2009)

  5. No Access

    Chapter

    Radioimmuntherapie

    Die Verwendung von monoklonalen Antikörpern als Träger für zytotoxische Reagenzien ist ein Konzept zur Verbesserung der Tumorbehandlung, das bereits Anfang des vorigen Jahrhunderts für Antiseren benutzt wurde.

    B. Wittig, A. Rieth, E. Enghofer in Kompendium Internistische Onkologie (2006)

  6. No Access

    Chapter

    Zellinvasion und Metastasierung

    Als Metastasierung wird der Prozess der Absiedlung und des Wachstums von Tumorzellen in einem vom Primärtumor entfernten Organ bezeichnet. Da der heutige Stand der medizinischen Technik die Entfernung nahezu j...

    M. Zöller, B. Wittig in Die Onkologie (2004)

  7. No Access

    Article

    The gut as an organ of immunology

    Abstract

    B. Wittig, M. Zeitz in International Journal of Colorectal Disease (2003)

  8. No Access

    Article

    Increased expression of interleukin-12 receptor β2 on lamina propria mononuclear cells of patients with active Crohn's disease

    Abstract

    A. Stallmach, T. Marth, N. Adrian, B. Wittig in International Journal of Colorectal Disease (2002)

  9. No Access

    Article

    The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice

    Background and aims: In chronic inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis an aberrant mucosal immune regulation is observed accompanied by upregulation of pr...

    K. Pfister, B. Wittig, B. Jüngling, K. Ecker in International Journal of Colorectal Disease (2002)

  10. No Access

    Article

    Proliferation-dependent induction of apoptosis by the retinoid CD437 in p53-mutated keratinocytes

    6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-Naphthalene carboxylic acid (CD437) is a synthetic retinoid with strong apoptogenic properties in various neoplastic cell lines. CD437 was shown to induce apoptosis in ma...

    R. Wanner, U. Henseleit-Walter, B. Wittig, G. Kolde in Journal of Molecular Medicine (2002)

  11. No Access

    Article

    Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs

    Dendritic cells (DCs) are the major antigen-presenting cells. They are able to present tumor antigens to immunologic effector cells. MHC class II molecules on DC surfaces play an important role in priming effe...

    Angela Märten, Carsten Ziske, Björn Schöttker, Silvia Weineck in Cancer Gene Therapy (2001)

  12. No Access

    Article

    Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation

    Background: Experiments were performed to determine whether corneal epithelium transfected with minimalistic immunologically defined expression constructs for the extracellular fragment of CTLA4 and for interleu...

    S.A. König Merediz, E.-P. Zhang, B. Wittig in Graefe's Archive for Clinical and Experime… (2000)

  13. Article

    Open Access

    Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma

    Natural killer-like T lymphocytes termed cytokine-induced killer (CIK) cells have been shown to eradicate established tumours in a severe combined immune deficient (SCID) mouse/human lymphoma model. Recently, ...

    I G H Schmidt-Wolf, S Finke, B Trojaneck, A Denkena in British Journal of Cancer (1999)

  14. No Access

    Article

    Regulation and possible function of axl expression in immature human mast cells

     The receptor tyrosine kinase Axl which expresses extracellular domains reminiscent of cell adhesion molecules, is involved in homotypic binding as well as in intracellular signaling of myeloid progenitor cells. ...

    I. Heide, A. C. Sokoll, B. M. Henz, S. Nagel, K. Kreißig in Annals of Hematology (1998)

  15. No Access

    Article

    Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study

    Recently, cytokine gene transfer into tumour cells has been shown to mediate tumour regression in animal models via immunomodulation. Consequently, a number of clinical protocols have been developed to treat c...

    P Möller, Y Sun, T Dorbic, S Alijagic, A Makki, K Jurgovsky in British Journal of Cancer (1998)

  16. No Access

    Article

    Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study

    Cytokine gene transfer into tumor cells has been shown to mediate tumor regression and antimetastatic effects in several animal models via immunomodulation. Therefore, clinical protocols have been developed to...

    Y Sun, K Jurgovsky, P Möller, S Alijagic, T Dorbic, J Georgieva, B Wittig in Gene Therapy (1998)

  17. No Access

    Chapter

    Functional Involvement of CD44, a Family of Cell Adhesion Molecules, in Immune Responses, Tumour Progression and Haematopoiesis

    Cell-cell and cell-extracellular matrix (ECM) interactions play fundamental roles in many biological processes. Cells adhere to the ECM and to each other via specific cell surface receptors such as the selecti...

    Ursula Günthert, C. Schwärzler, B. Wittig, J. Laman, P. Ruiz in Gene Therapy of Cancer (1998)

  18. No Access

    Chapter

    Inhibition of G Proteins by Antisense Drugs

    In a multicellular organism, cells communicate with each other mostly through the cell surface, which is represented by the plasma membrane with its lipids and proteins. A subset of the membrane proteins, i.e....

    F. Kalkbrenner, B. Wittig, G. Schultz in Antisense Research and Application (1998)

  19. No Access

    Article

    Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene

    Cytokine-induced killer (CIK) cells have been shown to eradicate established tumors in a SCID mouse–human lymphoma model. CIK cells depend on exogenous addition of cytokines such as interleukin-2 (IL-2), inter...

    S Finke, B Trojaneck, P Lefterova, M Csipai, E Wagner, R Kircheis in Gene Therapy (1998)

  20. No Access

    Chapter

    Immuntherapie

    Immuntherapeutische Verfahren bei Patienten mit malignen Tumoren können in aktive und passive Ansätze unterteilt werden. Unter aktiver Immuntherapie versteht man den Versuch, das Immunsystem des Patienten unsp...

    G. Schlimok, G. Riethmüller, U. Keilholz in Kompendium Internistische Onkologie (1996)

previous disabled Page of 2